Neurological Disorders and Diseases

Disease State Hub

Featured

Guideline Update
Guideline Update
09/21/2026
Anthony Calabro, MA
An updated evidence-based practice guideline published in Headache outlines when to initiate pharmacologic migraine prevention in adults and how to select, assess, and discontinue treatment.
09/21/2026
What's the Take Home?
What's the Take Home?
09/19/2026
Ronald N. Rubin, MD
A 55-year-old man presents with a subacute history of an unsteady, stumbling gait resulting in several falls during the last 2 weeks.
09/19/2026
FDA Approval
FDA Approval
09/16/2026
Anthony Calabro, MA
Clinical and pharmacokinetic evidence supported approval of zilganersen across pediatric and adult age groups, providing the first therapy designed to reduce production of the abnormal GFAP protein...
09/16/2026

Interactive Features

Pop Quiz
Pop Quiz
08/18/2026
Kate Young
A recent review investigated migraines in men. Do you know the what symptoms men are less likely to report compared with women? Take the quiz to test your knowledge!
08/18/2026
Pop Quiz
Pop Quiz
05/20/2026
Miranda Manier, BA
Could a simple change in nutrient intake help manage migraine attacks? Discover the dietary connections with this quick quiz!
05/20/2026
Pop Quiz
Pop Quiz
03/21/2025
Leigh Precopio
How long must a migraine attack last for it to be considered status migrainosus? Test your knowledge in our latest quiz.
03/21/2025
Pop Quiz
Pop Quiz
07/12/2024
Do you know which patient population NMOSD is most prevalent in? Test your knowledge with this quick quiz!
07/12/2024
Poll
Poll
07/06/2024
Although migraine is widely considered primarily a vascular disorder, this belief has evolved over the years. How would you now classify migraine? Let us know by taking this poll!
07/06/2024

Clinical Insights

Expert Q&A
Expert Q&A
09/14/2026
John W. Harrington, MD
A Reuters analysis found that the proportion of US newborns who did not receive a vitamin K injection within 1 day of birth increased by more than 57% from January through June 2026.
09/14/2026
Video Q&A
Video Q&A
06/22/2026
Rajesh R. Tampi, MD, MS, FAPA
In this video interview, Rajesh R. Tampi, MD, discusses how a new FDA-approved medication may fit into the treatment landscape for agitation associated with Alzheimer disease.
06/22/2026
Video
Video
04/21/2026
Sean Rose, MD
In this video interview, Sean Rose, MD, a pediatric neurologist at Nationwide Children’s Hospital and The Ohio State University, discusses new research examining how frequently children younger than 6 years...
04/21/2026
Video
Video
01/22/2026
Serena Orr, MD, MSc
In this video, Serena Orr, MD, MSc, speaks about her team’s study, “Anxiety and Depressive Symptoms and Disorders in Children and Adolescents With Migraine.” Dr Orr talks about how the results of the study...
01/22/2026
expert Q&A
expert Q&A
05/31/2024

Joseph Magagnoli, MS

Joseph Magagnoli, MS
Acetylcholinesterase inhibitors are frequently used in the treatment of Alzheimer disease due to their anti-inflammatory effects. But what is the potential of this class of medications to also impact the...
05/31/2024